Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?

Since dendritic cells operate as professional antigen-presenting cells (APCs) and hence are capable of jumpstarting the immune system, they have been exploited to develop a variety of immunotherapeutic regimens against cancer. In the few past years, myeloid-derived suppressor cells (MDSCs) have been...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Escors, David, Liechtenstein, Therese, Perez-Janices, Noemi, Schwarze, Julia, Dufait, Ines, Goyvaerts, Cleo, Lanna, Alessio, Arce, Frederick, Blanco-Luquin, Idoia, Kochan, Grazyna, Guerrero-Setas, David, Breckpot, Karine
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2013
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825722/
https://ncbi.nlm.nih.gov/pubmed/24244902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26148
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki